Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain

American Journal of Clinical Nutrition

Volumn 83, Issue 3, 2006, Pages 606-612

  Larsen, Thomas Meinert ^a   Toubro, Søren ^b   Gudmundsen, Ola ^c   Astrup, Arne ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c Scandinavian Clinical Research AS   (Norway)

Author keywords

Body fat; Conjugated linoleic acid; Dietary supplement; Obesity; Safety

Indexed keywords

CONJUGATED LINOLEIC ACID; OLIVE OIL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIET RESTRICTION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FLATULENCE; HUMAN; INSULIN RESISTANCE; LABORATORY TEST; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; WEIGHT CHANGE; WEIGHT GAIN; ADIPOSE TISSUE; ADOLESCENT; DIET THERAPY; DRUG EFFECT; LEUKOCYTE COUNT; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIODENSITOMETRY; SAFETY; TREATMENT OUTCOME;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; COMBINED MODALITY THERAPY; DENSITOMETRY, X-RAY; DIET, REDUCING; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMANS; LEUKOCYTE COUNT; LINOLEIC ACIDS, CONJUGATED; MALE; MIDDLE AGED; OBESITY; SAFETY; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 33645633309     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn.83.3.606     Document Type: Article

References (25)

1. Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr 2004;79:529-36.
2. Pariza MW. The University of Wisconsin-Madison website with references on conjugated linoleic acid (CLA). Version current 2005. Internet: http://www.wisc.edu/fri/clarefs.htm (accessed 19 Dec 2005).
3. Gaullier JM, Berven G, Blankson H, Gudmundsen O. Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids 2002;37:1019-25.
4. Jiang J, Wolk A, Vessby B. Relation between the intake of milk fat and the occurrence of conjugated linoleic acid in human adipose tissue. Am J Clin Nutr 1999;70:21-7.
5. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 2000;130:2943-8.
6. Gaullier JM, Halse J, Hoye K, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 2004;79:1118-25.
7. Gaullier JM, Halse J, Hoye K, et al. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 2005;135:778-84.
8. Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 2003;27:840-7.
9. Whigham LD, O'Shea M, Mohede IC, Walaski HP, Atkinson RL. Safety profile of conjugated linoleic acid in a 12-month trial in obese humans. Food Chem Toxicol 2004;42:1701-9.
10. Berven G, Bye A, Hals O, et al. Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur J Lipid Sci Technol 2000;102:455-62.
11. Astrup A, Pedersen U, Toubro S, Vedelspang A. Spis for livet. [Eat for life.] Copenhagen, Denmark: Aschehoug, 2002.
12. Sandström B, Aro A, Becker W, et al. Nordiska nä ringsrekommendationer 1996. [Nordic nutritional recommendations 1996.] Copenhagen, Denmark: Nordiska Ministerrådet, 1996.
13. Wang YW, Jones PJ. Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 2004;28:941-55.
14. Kritchevsky D, Tepper SA, Wright S, Tso P, Czarnecki SK. Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr 2000;19:472S-7S.
15. Henriksen EJ, Teachey MK, Taylor ZC, et al. Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat. Am J Physiol Endocrinol Metab 2003;285:E98-105.
16. Pariza MW. Conjugated linoleic acid may be useful in treating diabetes by controlling body fat and weight gain. Diabetes Technol Ther 2002;4:335-8.
17. Riserus U, Smedman A, Basu S, Vessby B. Metabolic effects of conjugated linoleic acid in humans: the Swedish experience. Am J Clin Nutr 2004;79(suppl):1146S-8S.
18. Larsen TM, Toubro S, Astrup A. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res 2003;44:2234-41.
19. Pariza MW. Perspective on the safety and effectiveness of conjugated linoleic acid. Am J Clin Nutr 2004;79(suppl):1132S-6S.
20. Clement L, Poirier H, Niot I, et al. Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 2002;43:1400-9.
21. Terpstra AH. Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature. Am J Clin Nutr 2004;79:352-61.
22. Riserus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002;25:1516-21.
23. Riserus U, Vessby B, Arnlov J, Basu S. Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 2004;80:279-83.
24. Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 2001;54:316-22.
25. Albers R, van der Wielen RP, Brink EJ, Hendriks HF, Dorovska-Taran VN, Mohede IC. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur J Clin Nutr 2003;57:595-603.